Zhao J, Huang F, Xu X, Zhang Y, Xing X, Huang J
Front Oncol. 2024; 14:1444431.
PMID: 39664178
PMC: 11631905.
DOI: 10.3389/fonc.2024.1444431.
Hayhow T, Williamson B, Lawson M, Cureton N, Braybrooke E, Campbell A
Commun Biol. 2024; 7(1):563.
PMID: 38740899
PMC: 11091220.
DOI: 10.1038/s42003-024-06238-x.
Min J, Lee G, Khanal T, Jin S, Lee S, Kim H
Am J Cancer Res. 2022; 12(6):2798-2816.
PMID: 35812067
PMC: 9251700.
Escher T, Lui A, Geanes E, Walter K, Tawfik O, Hagan C
Mol Cancer Res. 2019; 17(5):1180-1194.
PMID: 30655323
PMC: 6497545.
DOI: 10.1158/1541-7786.MCR-18-0916.
Kaymak A, Sayols S, Papadopoulou T, Richly H
Oncotarget. 2018; 9(47):28666-28690.
PMID: 29983888
PMC: 6033359.
DOI: 10.18632/oncotarget.25596.
siRNAs Targeting Growth Factor Receptor and Anti-Apoptotic Genes Synergistically Kill Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways.
Kamaruzman N, Tiash S, Ashaie M, Chowdhury E
Biomedicines. 2018; 6(3).
PMID: 29932151
PMC: 6164725.
DOI: 10.3390/biomedicines6030073.
Emerging Roles of Estrogen-Related Receptors in the Brain: Potential Interactions with Estrogen Signaling.
Saito K, Cui H
Int J Mol Sci. 2018; 19(4).
PMID: 29621182
PMC: 5979530.
DOI: 10.3390/ijms19041091.
Exploring the intrinsic differences among breast tumor subtypes defined using immunohistochemistry markers based on the decision tree.
Li Y, Tang X, Bai Z, Dai X
Sci Rep. 2016; 6:35773.
PMID: 27786176
PMC: 5082366.
DOI: 10.1038/srep35773.
Low Dose, Low Cost Estradiol Pellets Can Support MCF-7 Tumour Growth in Nude Mice without Bladder Symptoms.
Dall G, Vieusseux J, Unsworth A, Anderson R, Britt K
J Cancer. 2015; 6(12):1331-6.
PMID: 26640593
PMC: 4643089.
DOI: 10.7150/jca.10890.
Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.
Kocaturk B, Tieken C, Vreeken D, Unlu B, Engels C, de Kruijf E
J Thromb Haemost. 2015; 13(9):1683-93.
PMID: 26179105
PMC: 4560996.
DOI: 10.1111/jth.13049.
Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer.
Jia X, Hong Q, Lei L, Li D, Li J, Mo M
Oncotarget. 2015; 6(11):8648-62.
PMID: 25929338
PMC: 4496173.
DOI: 10.18632/oncotarget.3257.
Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling.
Dai X, Chen A, Bai Z
Sci Rep. 2014; 4:6566.
PMID: 25338681
PMC: 4206873.
DOI: 10.1038/srep06566.
Low levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol.
Marques M, Laflamme L, Benassou I, Cissokho C, Guillemette B, Gaudreau L
BMC Cancer. 2014; 14:524.
PMID: 25048790
PMC: 4223525.
DOI: 10.1186/1471-2407-14-524.
Mapping ERβ genomic binding sites reveals unique genomic features and identifies EBF1 as an ERβ interactor.
Le T, Sun M, Luo X, Kraus W, Greene G
PLoS One. 2013; 8(8):e71355.
PMID: 23951143
PMC: 3738513.
DOI: 10.1371/journal.pone.0071355.
The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?.
Aquino N, Sevigny M, Sabangan J, Louie M
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2012; 30(3):189-224.
PMID: 22970719
PMC: 3476837.
DOI: 10.1080/10590501.2012.705159.
Identification of an estrogen-regulated circadian mechanism necessary for breast acinar morphogenesis.
Rossetti S, Corlazzoli F, Gregorski A, Azmi N, Sacchi N
Cell Cycle. 2012; 11(19):3691-700.
PMID: 22935699
PMC: 3478319.
DOI: 10.4161/cc.21946.
Mouse models of estrogen receptor-positive breast cancer.
Mohibi S, Mirza S, Band H, Band V
J Carcinog. 2012; 10:35.
PMID: 22279420
PMC: 3263010.
DOI: 10.4103/1477-3163.91116.
p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers.
Shai A, Pitot H, Lambert P
Cancer Res. 2008; 68(8):2622-31.
PMID: 18413729
PMC: 2862766.
DOI: 10.1158/0008-5472.CAN-07-5266.
Estrogen receptor transcription and transactivation: Basic aspects of estrogen action.
Nilsson S, Gustafsson J
Breast Cancer Res. 2001; 2(5):360-6.
PMID: 11250729
PMC: 138658.
DOI: 10.1186/bcr81.
